Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment

Trial Profile

Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Feb 2015

At a glance

  • Drugs Dapsone (Primary) ; Doxycycline
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 06 Aug 2013 Actual initiation date changed from 1 Jun 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 06 Aug 2013 Planned end date changed from 1 Mar 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top